NCT07254013 Left Bundle Branch Area Pacing (LBBAP) Monitoring Assistant: Evaluation of Portable ECG Solution
| NCT ID | NCT07254013 |
| Status | Recruiting |
| Phase | — |
| Sponsor | MicroPort CRM |
| Condition | Bradycardia |
| Study Type | INTERVENTIONAL |
| Enrollment | 55 participants |
| Start Date | 2025-11-14 |
| Primary Completion | 2026-02-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 55 participants in total. It began in 2025-11-14 with a primary completion date of 2026-02-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To evaluate the capability to monitor LBB success criteria with the use of a Smart ECG system (ECG monitor, 12 leads ECG cable, ECG viewer software ) during a cardiac device implantation involving the placement of a pacing lead in interventricular septum area
Eligibility Criteria
Inclusion Criteria: * Subject with indication for LBBAP using an Electrophysiology ECG monitoring system (EP System) as part of pacemaker or CRT-P or CRT-D implant procedure (de novo implant, device revision or upgrade including LOT-CRT) * Subject signed and dated the ICF Exclusion Criteria: * Incapacitated subject or under guardianship * inability to understand the purpose of the study * Minor subjects * Non menopausal women * Patients implanted with other electrically active non cardiac devices.
Contact & Investigator
Dr Pierre- Antoine Catalan
PRINCIPAL INVESTIGATOR
University Hospital, Clermont-Ferrand
Frequently Asked Questions
Who can join the NCT07254013 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Bradycardia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07254013 currently recruiting?
Yes, NCT07254013 is actively recruiting participants. Contact the research team at maria.martino@crm.microport.com for enrollment information.
Where is the NCT07254013 trial being conducted?
This trial is being conducted at Besançon, France, Clermont-Ferrand, France, Grenoble, France, Montpellier, France.
Who is sponsoring the NCT07254013 clinical trial?
NCT07254013 is sponsored by MicroPort CRM. The principal investigator is Dr Pierre- Antoine Catalan at University Hospital, Clermont-Ferrand. The trial plans to enroll 55 participants.